Should I buy Align Technology (ALGN) stock or is it too late?

Align Technology · Health Care · price $159

See the full Align Technology (ALGN) profile

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: BMO Capital — 73% of its targets hit on this sector (239 calls tested). It aims for $209 (+32 %), call made on July 10, 2026, maturing on July 10, 2027 (49 d ago).

The 1 reliable analyst $209+32 %

The 5 other firms $220+39 %

How to read it: the 1 reliable firms are not filtered by optimism — 1 aim above the price, 0 below, hence their $209 median. “The 5 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on Align Technology

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
Jefferies	89 %	+31.8 %	9	$140 -12%
Stifel	60 %	+27.8 %	40	$210 +32%
Baird	62 %	+25.4 %	16	$276 +74%
Barclays	60 %	+9.5 %	5	$200 +26%
Morgan Stanley	56 %	+9.4 %	18	$188 +18%
UBS	50 %	+5.7 %	6	$185 +16%
B of A Securities	57 %	+1.9 %	7	$206 +30%
Piper Sandler	36 %	-6.3 %	33	$235 +48%

In short — Should you invest in Align Technology? Is it too late, still worth it? Analysts are overwhelmingly positive (83% buy, median target $215, i.e. +35%), and the most reliable on ALGN targets even higher. But it pays virtually no dividend. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

83% of analysts rate it a buy (Buy consensus, 6 ratings) — a sign of market conviction.
Median price target $215, i.e. +35% from the current price ($159).
The most reliable firm on ALGN, Mizuho (100% hit rate, 2 scored calls), targets $200 (call made on January 20, 2026, maturing on January 20, 2027) (+26%) in its most recent call, and $170 (call made on October 13, 2025, maturing on October 13, 2026) (+7%) in the one coming due soonest.

⚠️ Reasons to hesitate

The consensus is not unanimous: of 6 ratings, 1 is neutral.
A 12-month target is not a guaranteed path: the price can fall in the meantime.
No dividend: your return depends only on price appreciation.

The analyst consensus on ALGN

Median target $215 (+35%) · 6 ratings · Buy consensus

Strong Buy00%

Buy583%

Hold117%

Sell00%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Align Technology now?

We won't decide for you. The facts: 83% of analysts rate it a buy, median target $215 (+35%), and Mizuho (most reliable on ALGN, 100%) targets $200. Weigh that against valuation (P/E ~28). This is not personalized advice.

Is it too late to invest in Align Technology?

Not according to analysts: the median target ($215) is still +35% above the current price ($159) (most reliable on ALGN: Mizuho, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Align Technology still worth investing in?

It depends on the gap between the price ($159) and its estimated value: analysts target $215 on median (+35%), with 83% buys (most reliable on ALGN: Mizuho, 100%). Cross-check with their real reliability on ALGN and the cautions above. Information, not advice.

What's the main risk in buying ALGN?

The consensus is not unanimous: of 6 ratings, 1 is neutral.

→ Go deeper: the full Align Technology profile (consensus, analyst reliability, price target, performance).